rotation.to
Following this device: dark.
Free account
rotation.to
Sign in / Request free access
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

Alexander Blair Wilson

CLO, CSO, and Corp Secretary

Company insider

Files Form 4 as: CLO, CSO, and Corp Secretary, AEON Biopharma.

Every Form 4 they filed

In numbers

Trades disclosed
12
Buys
0
Sells
0
Bought
$0
Sold
$0
Companies
1
Companies where not an officer
0
First trade
21 Jul 2023
Last trade
4 Mar 2026
Last filed
5 Mar 2026

Companies traded

Where they are an officer
AEON AEON BiopharmaOfficer · Biotechnology · last 4 Mar 20260 buys · 0 sells

Activity over time

Not enough dated trades to draw.

Every trade

TradedCompanyWhatAmount
4 Mar 2026filed 5 Mar 2026AEON AEON BiopharmaBiotechnologySEC FORM 4 Code A—1,316,872 at $0.00filing
4 Mar 2026filed 5 Mar 2026AEON AEON BiopharmaBiotechnologySEC FORM 4 Code A—1,316,872 at $0.00filing
17 Feb 2026filed 5 Mar 2026AEON AEON BiopharmaBiotechnologySEC FORM 4 Code A—862,500 at $0.00filing
17 Feb 2026filed 5 Mar 2026AEON AEON BiopharmaBiotechnologySEC FORM 4 Code A—862,500 at $0.00filing
21 May 2025filed 23 May 2025AEON AEON Biopharmaoption or derivative · BiotechnologySEC FORM 4 Code A—1,316,872 at $0.00filing
31 Aug 2024filed 4 Sep 2024AEON AEON Biopharmaoption or derivative · BiotechnologySEC FORM 4 Code A—480,631 at $0.00filing
31 Aug 2024filed 4 Sep 2024AEON AEON BiopharmaBiotechnologySEC FORM 4 Code A—180,110 at $0.00filing
19 Mar 2024filed 21 Mar 2024AEON AEON Biopharmaoption or derivative · BiotechnologySEC FORM 4 Code A—81,300 at $0.00filing
21 Jul 2023filed 24 Jul 2023AEON AEON Biopharmaoption or derivative · BiotechnologySEC FORM 4 Code A—77,647 at $0.00filing
21 Jul 2023filed 24 Jul 2023AEON AEON Biopharmaoption or derivative · BiotechnologySEC FORM 4 Code A—12,656 at $0.00filing
21 Jul 2023filed 24 Jul 2023AEON AEON Biopharmaoption or derivative · BiotechnologySEC FORM 4 Code A—106,609 at $0.00filing
21 Jul 2023filed 24 Jul 2023AEON AEON Biopharmaoption or derivative · BiotechnologySEC FORM 4 Code A—81,428 at $0.00filing

News

No headline names them, or the companies they trade most, lately.

Sectors

No trade we could place in a sector.

Related people

Timothy P. Lynch10% owner · 10% owner at AEON Biopharma, filing Form 4 there in the last year
Marc ForthDirector · Director at AEON Biopharma, filing Form 4 there in the last year
Shelley B. ThunenDirector · Director at AEON Biopharma, filing Form 4 there in the last year
Jost FischerDirector · Director at AEON Biopharma, filing Form 4 there in the last year
Eric G. CarterDirector · Director at AEON Biopharma, filing Form 4 there in the last year